Members of our group have previously investigated the role of IGF-2 and IGFBP-7 in the extinction of fear memories [47,48] and as a potential drug target in Alzheimer’s disease (AD) [49]. Here, IGF2 is linked to early-onset autosomal dominant Alzheimer disease.